Volkow ND, Wang G-J, Tomasi D, Baler RD. Obesity and addiction: neurobiological overlaps. Obes Rev. 2013;14:2–18.
Google Scholar
Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci. 2005;8:555–60. 2005 85.
Google Scholar
Matikainen-Ankney BA, Kravitz AV. Persistent effects of obesity: a neuroplasticity hypothesis. Ann NY Acad Sci. 2018;1428:221–39.
Google Scholar
Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology. 2004;47:33–46.
Google Scholar
Thompson JL, Drysdale M, Baimel C, Kaur M, MacGowan T, Pitman KA, et al. Obesity-induced structural and neuronal plasticity in the lateral orbitofrontal cortex. Neuropsychopharmacol. 2017;42:1480–90. 2017 427.
Google Scholar
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.
Google Scholar
Nutt D, Erritzoe D, Carhart-Harris R. Psychedelic psychiatry’s brave new world. Cell. 2020;181:24–8.
Google Scholar
Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS, Kristiansen S, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacol. 2019;44:1328–34. 2019 447.
Google Scholar
Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170.
Google Scholar
Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. 2018;235:399–408.
Google Scholar
Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355.
Google Scholar
Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron. 2006;51:239–49.
Google Scholar
Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, Holst K, et al. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage. 2009;46:23–30.
Google Scholar
Haahr ME, Hansen DL, Fisher PM, Svarer C, Stenbæk DS, Madsen K, et al. Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals. J Neurosci. 2015;35:5884–9.
Google Scholar
Galen KA, van, Horst KW, ter, Serlie MJ. Serotonin, food intake, and obesity. Obes Rev. 2021;22:e13210.
Google Scholar
Fletcher PJ, Burton MJ. Microstructural analysis of the anorectic action of peripherally administered 5-HT. Pharm Biochem Behav. 1986;24:1133–6.
Google Scholar
Lam DD, Przydzial MJ, Ridley SH, Yeo GSH, Rochford JJ, O’Rahilly S, et al. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology. 2008;149:1323–8.
Google Scholar
Galen KA, van, Horst KW, ter, Booij J, Fleur SE, la, Serlie MJ. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. Metab – Clin Exp. 2018;85:325–39.
Google Scholar
Tilson HA, Marquis WJ, Rech RH. Effects of d-aphetamine, 2,5-dimethoxy-4-methylamphetamine (DOM), and psilocybin on fixed-interval responding in the rat Proc. Am. Psychol. Ass. (1973).
Vaupel DB, Nozaki M, Martin WR, Bright LD, Morton EC. The inhibition of food intake in the dog by LSD, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives. Life Sci. 1979;24:2427–31.
Google Scholar
Flanagan TW, Sebastian MN, Battaglia DM, Foster TP, Maillet EL, Nichols CD. Activation of 5-HT 2 receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein E knockout mice. Sci Rep 2019;9:13444.
Simonsson O, Sexton JD, Hendricks PS. Associations between lifetime classic psychedelic use and markers of physical health. J Psychopharmacol. 2021;35:447–52.
Google Scholar
Corne SJ, Pickering RW. A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. Psychopharmacol. 1967;11:65–78.
Google Scholar
Czyzyk TA, Sahr AE, Statnick MA. A model of binge-like eating behavior in mice that does not require food deprivation or stress. Obesity (Silver Spring). 2010;18:1710–1717.
Google Scholar
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. Sequence analysis STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013;29:15–21.
Frankish A, Diekhans M, Ferreira AM, Johnson R, Jungreis I, Loveland J, et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019;47:D766–73.
Google Scholar
Liao Y, Smyth GK, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013;41:e108–e108.
Google Scholar
Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.
Google Scholar
Law CW, Chen Y, Shi W, Smyth GK. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:1–17.
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47–e47.
Google Scholar
Wu D, Smyth GK. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 2012;40:e133–e133.
Google Scholar
Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016.
Halberstadt AL, Koedood L, Powell SB, Geyer MA. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol. 2011;25:1548–61.
Google Scholar
Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharm. 2003;463:3–33.
Google Scholar
Jefsen OH, Elfving B, Wegener G, Müller HK. Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin. J Psychopharmacol. 2021;35:483–93.
Google Scholar
Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. J Psychopharmacol. 2019;33:1088–101.
Google Scholar
Robert L, Collins BD, Mark Ordy DJ, Thaddeus Samorajski D. Psilocin effects on behaviour and brain serotonin in mice. Trans Assoc Am Physicians. 1961;7:379.
Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. Acute psychological and physiological affects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology (Berlin). 2004;172:145–56.
Google Scholar
Friedman SA, Hirsch SE. Extreme hyperthermia after LSD ingestion. JAMA. 1971;217:1549–50.
Google Scholar
Hollister LE, Sjoberg BM. Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin and a combination of the three psychotomimetic drugs. Compr Psychiatry. 1964;5:170–8.
Google Scholar
Flanagan TW, Sebastian MN, Battaglia DM, Foster TP, Maillet EL, Nichols CD. Activation of 5-HT2 receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein E knockout mice. Sci Rep 2019;9.
Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, et al. Acute effects of lysergic acid diethylamide in healthy subjects. Biol Psychiatry. 2015;78:544–53.
Google Scholar
Guy-Grand B, Crepaldi G, Vre PL, Apfelbaum M, Gries A, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet. 1989;334:1142–5.
Google Scholar
Fox MA, French HT, Laporte JL, Blackler AR, Murphy DL. The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis. Psychopharmacology (Berlin). 2010;212:13–23.
Google Scholar
Aulakh CS, Mazzola-Pomietto P, Hulihan-Giblin BA, Murphy DL. Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and S-HT2c receptors, respectively. Neuropsychopharmacology 1995;13:1–8
Anderberg RH, Richard JE, Eerola K, López-Ferreras L, Banke E, Hansson C, et al. Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight. Diabetes. 2017;66:1062–73.
Google Scholar
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science (80-). 1995;269:540–3.
Google Scholar
Collin M, Håkansson-Ovesjö ML, Misane I, Ögren SO, Meister B. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Mol Brain Res. 2000;81:51–61.
Google Scholar
Rowland NE. Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: body weight and brain serotonin changes. Pharm Biochem Behav. 1994;49:287–94.
Google Scholar
Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams L-A, Hui K, et al. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology (Berlin) 2019;236:731–40.
Johnstad PG. Powerful substances in tiny amounts: an interview study of psychedelic microdosing. Nordisk Alkohol Nark. 2018;35:39–51.
Google Scholar
Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry. 2021;11:1–10. 2021 111.
Google Scholar
Nonogaki K, Kaji T. Liraglutide, a GLP-1 receptor agonist, which decreases hypothalamic 5-HT2A receptor expression, reduces appetite and body weight independently of serotonin synthesis in mice. J Diab Res 2018;2018.
Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. 2014;28:983–92.
Google Scholar
Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa P, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015;29:289–99.
Google Scholar
Meinhardt MW, Güngör C, Skorodumov I, Mertens LJ, Spanagel R. Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. Neuropsychopharmacol. 2020;45:1316–22. 2020 458.
Google Scholar
Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, et al. Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Sci Adv. 2021;7:2399.
Google Scholar
Czyzyk TA, Sahr AE, Statnick MA. A model of binge-like eating behavior in mice that does not require food deprivation or stress. Obesity. 2010;18:1710–7.
Google Scholar
Hagan MM, Rushing PA, Benoit SC, Woods SC, Seeley RJ. Opioid receptor involvement in the effect of AgRP- (83–132) on food intake and food selection. Am J Physiol Integr Comp Physiol. 2001;280:R814–21.
Google Scholar
Liu Y, Yin C-Y, Zhu L-J, Zhu X-H, Xu C, Luo C-X, et al Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc n.d.; 2018;13:1686–1698.
Shao L-X, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron. 2021;109:2535–44.e4.
Google Scholar
Ilic K, Mlinac-Jerkovic K, Sedmak G, Rosenzweig I, Kalanj-Bognar S. Neuroplastin in human cognition: review of literature and future perspectives. Transl Psychiatry. 2021;11:1–8. 2021 111.
Google Scholar
Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci. 2007;27:14265–74.
Google Scholar
Boender AJ, van Gestel MA, Garnerv KM, Luijendijk MCM, Adan RAH. The obesity-associated gene Negr1 regulates aspects of energy balance in rat hypothalamic areas. Physiol Rep. 2014;2:e12083.
Google Scholar
Martin-Gronert MS, Stocker CJ, Wargent ET, Cripps RL, Garfield AS, Jovanovic Z, et al. 5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats. Dis Model Mech. 2016;9:401.
Google Scholar
Ochner CN, Tsai AG, Kushner RF, Wadden TA. Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations. Lancet Diabetes Endocrinol. 2015;3:232–4.
Google Scholar
Ochner CN, Barrios DM, Lee CD, Pi-Sunyer FX. Biological mechanisms that promote weight regain following weight loss in obese humans. Physiol Behav. 2013;120:106–13.
Google Scholar
Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs. placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 Randomized Clinical Trial. JAMA. 2021;325:1414–25.
Google Scholar
Müller TD, Blüher M, Tschöp MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2021;2021:1–23.
Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abus. 2017;43:55.
Google Scholar
Le Berre AP, Fama R, Sullivan EV. Executive functions, memory, and social cognitive deficits and recovery in chronic alcoholism: a critical review to inform future research. Alcohol Clin Exp Res. 2017;41:1432.
Google Scholar
Zhao J, Manza P, Gu J, Song H, Zhuang P, Shi F, et al. Contrasting dorsal caudate functional connectivity patterns between frontal and temporal cortex with BMI increase: link to cognitive flexibility. Int J Obes. 2021;45:2608–16. 2021 4512.
Google Scholar
Perpiñá C, Segura M, Sánchez-Reales S. Cognitive flexibility and decision-making in eating disorders and obesity. Eat Weight Disord. 2017;22:435–44.
Google Scholar
Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, et al. Study protocol for “psilocybin as a treatment for anorexia nervosa: a Pilot Study. Front Psychiatry. 2021;12:1770.
Google Scholar
Huang XF, Huang X, Han M, Chen F, Storlien L, Lawrence AJ. 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Brain Res. 2004;1018:227–35.
Google Scholar
Chen R, Wu X, Jiang L, Zhang Correspondence Y. Single-cell RNA-Seq reveals hypothalamic cell diversity. CellReports. 2017;18:3227–41.
Google Scholar
Gluck ME, Viswanath P, Stinson EJ. Obesity, appetite, and the prefrontal cortex. Curr Obes Rep 2017;6:380–388.
